10.19.21
Nanliu, established in 1978 and listed on the Taiwan stock exchange, has grown into a world leading producer of nonwovens for the wipes, hygiene, and medical markets. It has always been known for its broad portfolio of sustainable products and unique manufacturing capability. The recent implementation of the marking requirements of the Single-Use Plastics (SUP) directive creates new business opportunities for Nanliu. It is ready for clients looking for sustainable product alternatives. With FSC viscose and lyocell fabrics being produced for many years in both its Taiwan and China operations, Nanliu has now also started to roll out its cotton spunlace fabrics. Its new Taiwan plant houses the latest technology to produce pure organic cotton spunlace.
Nanliu has a vast range of spunlace nonwovens, air-through fabrics, woodpulp/polyester for surgical gowns and drapes and for low-lint industrial wipes. It also offers OEM/ODM for wipes, facial masks, and skin care lotion products. Its products are famed for its high and consistent quality and quality control. Its woodpulp/polyester fabric is one of the very few that has consistently been selling, according to European EN 13795 and US AAMI 2 requirements for use in surgical garments. A newly-built plant in Ahmedabad, India, will start production towards the end of this year starting with production of air-through fabrics and wet wipes.
Nanliu has a vast range of spunlace nonwovens, air-through fabrics, woodpulp/polyester for surgical gowns and drapes and for low-lint industrial wipes. It also offers OEM/ODM for wipes, facial masks, and skin care lotion products. Its products are famed for its high and consistent quality and quality control. Its woodpulp/polyester fabric is one of the very few that has consistently been selling, according to European EN 13795 and US AAMI 2 requirements for use in surgical garments. A newly-built plant in Ahmedabad, India, will start production towards the end of this year starting with production of air-through fabrics and wet wipes.